Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nemaura Medical Announced The UK Launch Of Its Approach To Metabolic Health And Weight Management By Integrating Continuous Glucose Monitoring With Its Behavioral Change Program, Miboko, Complemented By Pharmaceutical Interventions Using GLP-1 Agonist

Author: Benzinga Newsdesk | November 14, 2023 09:08am

Posted In: NMRD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist